Here, we reported that RBM10 acts as a regulator of c-Myc to reduce c-Myc stability and activity by partnering with the two ribosomal proteins uL18 and uL5, consequently suppressing the proliferation of human lung cancer cells and the growth of their xenograft tumors. The gene discussed is RPL5; the disease is lung cancer.